The aim of the study was to assess the completeness and accuracy of ca
ncer registration for cutaneous malignant melanoma. The study was cond
ucted in seven health districts in England and one health board in Sco
tland from 1987 to 1989 with a total resident population of 3.6 millio
n. Records from pigmented lesion clinics and pathology laboratories co
llected during the Cancer Research Campaign's health education program
me to promote the early detection of melanoma were matched with cancer
registrations from a total of five regional cancer registries. In Eng
land 74% out of a total of 642 cases of invasive malignant melanomas (
ICD 172) and 44% out of a total of 155 in situ melanomas (ICD 232) had
been registered compared with 96% and 100% respectively in Scotland.
A significantly higher proportion of late-stage cases was found among
registered than among non-registered cases in England (P<0.001). In al
l registries the majority of superficial spreading in situ melanomas w
ere miscoded as invasive cases. The annual incidence of invasive malig
nant melanoma in the English study areas was found to be seven per 100
000 in men and 11 per 100 000 in women, similar to that reported in S
cotland. The registries are best at recording thick or late-stage mela
nomas. As the skin cancer target for Health of the Nation depends on m
onitoring trends in the incidence of malignant melanoma, future improv
ed ascertainment of cases and changes in the type of cases being regis
tered must be taken into account.